Method of determining a pharmaceutical combination preparations for use in anti-neoplastic therapy

摘要

The present invention provides a pharmaceutical combination preparation, wherein it contains at least two active materials, the first active material being an inhibitor of protein kinase C and the other active material having an anti-neoplastic action, as well as pharmacologically acceptable carriers and adjuvants.